ERAS
Erasca Inc
NASDAQ: ERAS · HEALTHCARE · BIOTECHNOLOGY
$9.11
-7.98% today
Updated 2026-04-29
Market cap
$6.68B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$1 – $24
Volume
6.9M
Erasca Inc (ERAS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+4.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+9.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+8.1%
2026-03-19
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.10 | +8.3% | $13.50 | $14.60 | +8.1% |
| 2025-11-12 | $-0.11 | -5.8% | $2.36 | $2.54 | +7.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.11 | $-0.10 | +8.3% | — | — |
| 2025-09-30 | $-0.10 | $-0.11 | -5.8% | — | — |
| 2025-06-30 | $-0.12 | $-0.12 | +0.0% | — | — |
| 2025-03-31 | $-0.13 | $-0.11 | +15.4% | — | — |
| 2024-12-31 | $-0.13 | $-0.11 | +15.4% | $4.20M | -24.8% |
| 2024-09-30 | $-0.17 | $-0.11 | +35.3% | — | — |
| 2024-06-30 | $-0.18 | $-0.29 | -61.1% | — | — |
| 2024-03-31 | $-0.20 | $-0.23 | -15.0% | — | — |
| 2023-12-31 | $-0.23 | $-0.20 | +13.0% | $5.58M | — |
| 2023-09-30 | $-0.22 | $-0.20 | +9.1% | — | — |
| 2023-06-30 | $-0.24 | $-0.21 | +12.5% | — | — |
| 2023-03-31 | $-0.31 | $-0.22 | +29.0% | — | — |
Frequently asked questions
Has Erasca Inc beaten earnings estimates?
Erasca Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +4.5% over the last 4 quarters.
How does ERAS stock react to earnings?
ERAS stock has moved an average of +7.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.